Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CRDLCRDL
20 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in CARDIOL THERAPEUTICS INC

Yes. Geode Capital Management holds 42,196 shares of CRDL (Cardiol Therapeutics), worth $44,727, as of its Q2 2026 13F filing. It reduced the position by 10,239 shares (-19.5%) from Q1 2026. Geode Capital Management has held CRDL since Q3 2021, across 20 quarterly 13F filings.

Current Value

$44,727

Current Shares

42,196

Total Value Change

-$172,273

Total Shares Change

-10,239

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
42,196
-19.5%
$44,7270.0%$1.06
0
2026-Q1
Unchanged
52,435
0.0%
$70,7870.0%$1.35
0
2025-Q4
Unchanged
52,435
0.0%
$50,0120.0%$0.95
0
2025-Q3
Unchanged
52,435
0.0%
$56,1050.0%$1.07
0
2025-Q2
Unchanged
52,435
0.0%
$71,3110.0%$1.36
0
2025-Q1
Unchanged
52,435
0.0%
$50,8510.0%$0.97
0
2024-Q4
Unchanged
52,435
0.0%
$67,1160.0%$1.28
0
2024-Q3
Unchanged
52,435
0.0%
$103,8210.0%$1.98
0
2024-Q2
Unchanged
52,435
0.0%
$105,9180.0%$2.02
0
2024-Q1
Unchanged
52,435
0.0%
$94,9070.0%$1.81
0
2023-Q4
Unchanged
52,435
0.0%
$44,0450.0%$0.84
0
2023-Q3
Unchanged
52,435
0.0%
$48,2400.0%$0.90
0
2023-Q2
Unchanged
52,435
0.0%
$46,6670.0%$0.89
0
2023-Q1
Unchanged
52,435
0.0%
$25,5510.0%$0.49
0
2022-Q4
Unchanged
52,435
0.0%
$26,0000.0%$0.51
0
2022-Q3
Unchanged
52,435
0.0%
$54,0000.0%$1.03
0
2022-Q2
Unchanged
52,435
0.0%
$69,0000.0%$1.32
0
2022-Q1
Unchanged
52,435
0.0%
$80,0000.0%$1.53
0
2021-Q4
Unchanged
52,435
0.0%
$97,0000.0%$1.85
0
2021-Q3
New
52,435
-
$217,0000.0%$4.15
35

Other major holders of CRDL: Mirae Asset Global Investments Co., Ltd., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used